If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,082.00    -380.00 (-25.99%)
Bid:
1,092.00
Ask:
1,098.00
Spread: 6.00 (0.549%)
Market Cap: £370.45m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Update

15 Jul 2014 07:00

RNS Number : 2877M
Craneware plc
15 July 2014
 



 Craneware plc

("Craneware", "the Group" or the "Company")

Trading Update and Notice of Results

 

 

15 July 2014 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2014.

 

The Board is pleased to confirm the increased sales activity reported earlier in the year  has delivered a record sales performance for the Group with the total value of contracts signed in the year increasing to over  $70m (FY13: $38.5m), an increase in excess of 80% on the prior year.

 

In accordance with the Group's revenue recognition policy, which is focussed on long term sustainable growth and mitigates against year on year fluctuations in the total value of contracts signed, the vast majority of the revenue from these sales has not been recognised in the year to 30 June 2014, and will instead benefit future years. Accordingly the Group expects to report revenues in a range of $42.2m to $43m (FY13: $41.5m) and deliver an adjusted EBITDA in a range of $12.8m to $13.2m (FY13: $12.4m).

 

The market for revenue integrity solutions continues to develop with larger and more complex hospital systems becoming an increasing part of both current year sales and the pipeline of sales opportunities. We continue to invest in our sales organisation to ensure we are optimally positioned to take advantage of this growing market opportunity. Management believes as the fiscal and regulatory pressures on US hospitals continue to grow, the strength and relevance of our unique suite of solutions will increase in this market environment, giving us confidence in continued future growth.

 

Keith Neilson, CEO of Craneware plc commented, "We are delighted to announce a record sales year for the Group, with a year on year increase of over 80% in the total value of contracts signed in the year, demonstrating the ongoing strength of our market position. The current sales success gives Craneware certainty over contracted revenue and associated profits upon which to build future growth."

 

The Company will announce its Full Year Results on 16th September 2014.

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Newgate Threadneedle

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

Heather Armstrong

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGMNNDMGDZM
Date   Source Headline
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20233:52 pmRNSVesting of Long Term Incentive Plan Awards
3rd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
27th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSFY23 Trading Update and Notice of Results
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20234:44 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.